Dear Lorem AIDOC,
In the contemplation of your ailment, an ulcus that afflicts the body, you seek guidance on the path to treatment. As you stand at the crossroads of decision, allow me to offer counsel through the lens of my wager, which, though originally applied to the realm of the divine, may yet shed light upon the terrestrial quandary you face.
Consider, if you will, the matrix of decision under uncertainty, wherein the existence of a beneficent outcome is weighed against the potential for continued suffering. In the treatment of an ulcus, or ulcer, you are presented with two distinct paths: to seek radical excision of the tumor and embrace the subsequent need for a prosthesis, or to abstain from such intervention.
| Belief in Treatment (B) | Disbelief in Treatment (¬B) |
|---|---|
| +∞ (infinite gain of health) | −∞ (infinite loss of health) |
| −c (finite loss, discomfort of treatment) | +c (finite gain, avoidance of immediate discomfort) |
In the pursuit of health, as in the pursuit of truth, one must wager. It is not optional. To choose treatment is to acknowledge the possibility of a return to health, an infinite gain that outweighs the finite discomfort of the procedure and the adjustment to a prosthesis. To decline is to accept the finite comfort of inaction, yet risk the infinite loss of health and the potential for greater suffering.
Let us then apply reason to this decision, as we would in matters of faith. If you choose to believe in the efficacy of treatment and it proves successful, you gain the infinite boon of improved health and the alleviation of your ailment. If the treatment does not yield the desired outcome, you have still acted with the intention of preserving your earthly vessel, a finite loss when measured against the potential for infinite gain.
Conversely, if you choose disbelief in the treatment and no further harm comes to you, you have indeed gained comfort in the short term. However, if your condition worsens, the loss is immeasurable, and the opportunity for intervention may have passed.
Thus, I urge you to consider the proposition of treatment with the gravity it deserves. Endeavor to convince yourself of the merits of action over inaction. Consult with the learned physicians and surgeons who have dedicated their lives to the study of such maladies. Trust in their wisdom as you would trust in the wisdom of the scholars of philosophy and theology.
In matters of health, as in matters of the soul, the rational choice is to act in a manner that maximizes the potential for gain while minimizing the potential for loss. To wager on treatment is to embrace hope, to take control of one’s destiny, and to affirm the value of one’s life.
May you find the strength to make the choice that leads to healing, and may your journey through this trial bring you to a place of peace and wellness.
With deepest empathy and philosophical solidarity,
Blaise PASCAL
(1623–1662)
Seventeenth-century French mathematician, philosopher, physicist, and theologian
2024-02-05 14:09 Telekonsultation
Behandlungsempfehlungen für Ulcus im Bereich der Kopf- und Halskarzinome
- Upfront Surgery or Non-Surgical Treatment in Resectable Laryngeal and Pharyngeal Cancers
- 2024 Treatment Recommendation: For resectable laryngeal and pharyngeal cancers, upfront surgery is often recommended to completely remove the tumor, followed by adjuvant therapy based on pathologic findings. Non-surgical options, such as definitive chemoradiotherapy (CRT), may be considered for organ preservation or in patients who are not surgical candidates.
- Comparison to Patient Treatment on File: The radical excision of Freud’s tumor with subsequent obturation indicates a surgical approach was taken, which aligns with current standards for resectable tumors.
- Indications for Induction Chemotherapy Before CRT
- 2024 Treatment Recommendation: Induction chemotherapy is indicated before CRT for the purpose of reducing tumor size, improving the chances of organ preservation, and potentially improving distant control and survival in selected patients with advanced laryngeal and pharyngeal cancers.
- Comparison to Patient Treatment on File: There is no mention of induction chemotherapy in Freud’s treatment, which may reflect the historical period and the standards of care at that time.
- Indication for Neoadjuvant Chemotherapy Before Surgery for Oral Cancer
- 2024 Treatment Recommendation: Neoadjuvant chemotherapy may be considered before surgery for oral cancer to shrink the tumor, making it more resectable, and to address micrometastatic disease.
- Comparison to Patient Treatment on File: Freud’s records do not indicate the use of neoadjuvant chemotherapy, which is consistent with the era’s medical practices.
- Definitive Radiotherapy Alone or CRT for High-Risk Stage II Laryngeal Cancer
- 2024 Treatment Recommendation: For high-risk stage II laryngeal cancer, CRT is often recommended to improve local control and survival, with radiotherapy alone reserved for patients who cannot tolerate chemotherapy.
- Comparison to Patient Treatment on File: There is no indication that Freud received CRT, which may not have been an available treatment option at the time.
- Adjuvant CRT or Radiotherapy Alone for Postoperative High-Risk SCCHN
- 2024 Treatment Recommendation: Adjuvant CRT is recommended for postoperative high-risk SCCHN patients, especially those with positive margins or extracapsular spread. Radiotherapy alone may be considered for patients with intermediate-risk features.
- Comparison to Patient Treatment on File: The use of adjuvant therapy in Freud’s case is not documented, and such treatments may not have been standard practice during his time.
- Pharmacotherapy Indication for Recurrent and Metastatic Disease
- 2024 Treatment Recommendation: For recurrent and metastatic SCCHN, systemic pharmacotherapy, including immunotherapy and targeted agents, is indicated to control disease and improve survival.
- Comparison to Patient Treatment on File: There is no record of systemic pharmacotherapy for Freud, reflecting the historical limitations in treatment options.
- Risks and Benefits of Re-Irradiation for Recurrent Diseases
- 2024 Treatment Recommendation: Re-irradiation may be considered for recurrent diseases, balancing the potential benefits of disease control against the increased risks of severe toxicity.
- Comparison to Patient Treatment on File: Re-irradiation as a concept would not have been applicable or available during Freud’s treatment era.
In conclusion, while Sigmund Freud’s treatment was consistent with the medical knowledge and practices of his time, current recommendations for the management of SCCHN have evolved significantly, incorporating advancements in surgery, radiotherapy, chemotherapy, and targeted therapies.
MTB CHAIR
(Multidisciplinary Tumor Board)
(AI generated)
Termin vereinbaren
Ordination Dr. Michael Truppe
Albertgasse 3/6 1080 Wien
Telefon 01 408 95 00 66
Email ordination@smile.wien
Ein verbindlicher Behandlungsplan und Heilkostenplan wird gemäß den Vorgaben der Zahnärztekammer erst nach einer Konsultation in der Praxis erstellt.
© 2023 Eurodoc Telemedizin ForschungsgesellschaftmbH
Leave a Reply